Showing results (2161-2170 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|September 16, 2017
Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanismsPeter P Ruvolo, Huaxian Ma, Vivian R Ruvolo, et al.Haematologica|September 28, 2019
Oral arsenic trioxide ORH-2014 pharmacokinetic and safety profile in patients with advanced hematologic disordersFarhad Ravandi, Iphigenia Koumenis, Anandhi Johri, et al.Haematologica|September 28, 2019
Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic populationOrna Steinberg-Shemer, Tracie A Goldberg, Joanne Yacobovich, et al.Haematologica|April 1, 2017
A three-dimensional ex vivo tri-culture model mimics cell-cell interactions between acute myeloid leukemia and the vascular nicheLaura J Bray, Marcus Binner, Yvonne Körner, et al.Haematologica|September 21, 2019
The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cellsWilliam Townsend, Marta Pasikowska, Deborah Yallop, et al.Haematologica|September 21, 2019
Genetic platelet depletion is superior in platelet transfusion compared to current modelsManuel Salzmann, Waltraud C Schrottmaier, Julia B Kral-Pointner, et al.Haematologica|September 21, 2019
Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibitionAmal Kamal Abdel-Aziz, Isabella Pallavicini, Elena Ceccacci, et al.Haematologica|October 5, 2019
IGHV mutational status and outcome for patients with chronic lymphocytic leukemia upon treatment: a Danish nationwide population-based studyEmelie Curovic Rotbain, Henrik Frederiksen, Henrik Hjalgrim, et al.Haematologica|October 5, 2019
Coactosin-like 1 integrates signaling critical for shear-dependent thrombus formation in mouse plateletsInga Scheller, Simon Stritt, Sarah Beck, et al.Haematologica|October 5, 2019
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow TransplantationAndré Tichelli, Régis Peffault de Latour, Jakob Passweg, et al.Pageof 816